{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:20:36Z","timestamp":1793481636293,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1270,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.seizure.2009.11.005","type":"journal-article","created":{"date-parts":[[2009,12,25]],"date-time":"2009-12-25T04:11:12Z","timestamp":1261714272000},"page":"69-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Seizure risk associated with neuroactive drugs: Data from the WHO adverse drug reactions database"],"prefix":"10.1016","volume":"19","author":[{"given":"Eva","family":"Kumlien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Olov","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2009.11.005_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A Bayesian neural network method for adverse drug reaction signal generation","volume":"54","author":"Bate","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.seizure.2009.11.005_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199410020-00001","article-title":"Harmonisation in pharmacovigilance","volume":"10","author":"Edwards","year":"1994","journal-title":"Drug Saf"},{"key":"10.1016\/j.seizure.2009.11.005_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1526-4610.1989.hed2907441.x","article-title":"Drug-related headache","volume":"29","author":"Askmark","year":"1989","journal-title":"Headache"},{"key":"10.1016\/j.seizure.2009.11.005_bib4","first-page":"97","article-title":"Sexual dysfunction as a suspected adverse reaction to antidepressants drugs","volume":"2","author":"Lundberg","year":"1998","journal-title":"Scan Sexol"},{"key":"10.1016\/j.seizure.2009.11.005_bib5","first-page":"457","article-title":"Sexual dysfunction as a suspected drug reaction reported to WHO Collaborating Centre for International Drug Monitoring","volume":"48","author":"Lundberg","year":"1993","journal-title":"Therapies"},{"key":"10.1016\/j.seizure.2009.11.005_bib6","first-page":"238","article-title":"Psychiatric morbidity in epilepsy: a case control study of adults receiving disability benefits","volume":"64","author":"Stefansson","year":"1998","journal-title":"JNNP"},{"key":"10.1016\/j.seizure.2009.11.005_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0091-3057(90)90068-S","article-title":"Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse","volume":"36","author":"Burke","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.seizure.2009.11.005_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1527-3458.2001.tb00207.x","article-title":"SCH 23390: the first selective dopamine D1-like receptor antagonist","volume":"7","author":"Bourne","year":"2001","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.seizure.2009.11.005_bib9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1212\/WNL.17.9.869","article-title":"Spontaneous epileptic seizures and electrographic changes in the course of phenothiazine therapy","volume":"17","author":"Logothetis","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2009.11.005_bib10","first-page":"S68","article-title":"Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations","volume":"53","author":"Alldrege","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2009.11.005_bib11","first-page":"184","article-title":"Seizures associated with clozapine treatment in a state hospital","volume":"55","author":"Wilson","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.seizure.2009.11.005_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1098-2396(199807)29:3<272::AID-SYN10>3.0.CO;2-V","article-title":"Acute and chronic administration of clozapine produces greater proconvulsant actions than haloperidol on focal hippocampal seizures in freely moving rats","volume":"29","author":"Minabe","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.seizure.2009.11.005_bib13","series-title":"Physicians\u2019 desk reference","year":"1999"},{"key":"10.1016\/j.seizure.2009.11.005_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yebeh.2005.05.014","article-title":"Anxiety in patients with epilepsy: systematic review and suggestions for clinical management","volume":"7","author":"Beyenburg","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2009.11.005_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/1531-8249(200002)47:2<246::AID-ANA17>3.0.CO;2-E","article-title":"Major depression is a risk factor for seizures in older adults","volume":"47","author":"Hesdorffer","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2009.11.005_bib16","first-page":"289","article-title":"Seizures associated with antidepressants: a review","volume":"54","author":"Rosenstein","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.seizure.2009.11.005_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00002018-200225020-00004","article-title":"Effects of psychotropic drugs on seizure threshold","volume":"25","author":"Pisani","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.seizure.2009.11.005_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2005.01.006","article-title":"Bupropion-induced convulsions: preclinical evaluation of antiepileptic drugs","volume":"64","author":"Tutka","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2009.11.005_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.yebeh.2005.07.014","article-title":"The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant","volume":"7","author":"Jobe","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2009.11.005_bib20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0006-2952(96)00509-6","article-title":"Antidepressants and seizures: clinical anecdotes overshadow neuroscience","volume":"52","author":"Daily","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.seizure.2009.11.005_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0736-4679(97)00072-3","article-title":"Fluoxetine versus tricyclic antidepressants: a prospective multicenter study of antidepressant drug overdoses","volume":"15","author":"Philips","year":"1997","journal-title":"J Emerg Med"},{"key":"10.1016\/j.seizure.2009.11.005_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-199920030-00007","article-title":"Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system","volume":"20","author":"Spigset","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.seizure.2009.11.005_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0920-1211(87)90028-3","article-title":"Migraine\u2013epilepsy relationships","volume":"1","author":"Andermann","year":"1987","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2009.11.005_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C","article-title":"The role of dopamine in epilepsy","volume":"22","author":"Starr","year":"1996","journal-title":"Synapse"},{"issue":"S5","key":"10.1016\/j.seizure.2009.11.005_bib25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1528-1167.2007.01300.x","article-title":"Cholinergic dysfunction in temporal lobe epilepsy","volume":"48","author":"Friedman","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2009.11.005_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","article-title":"Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system","volume":"47","author":"Dani","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131109002337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131109002337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:38:44Z","timestamp":1761010724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131109002337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1059131109002337"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2009.11.005","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizure risk associated with neuroactive drugs: Data from the WHO adverse drug reactions database","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2009.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}